Skip to main content
. 2020 Apr 19;21(8):2845. doi: 10.3390/ijms21082845
tPA tissue plasminogen activator
MT mechanical thrombectomy
BBB blood–brain barrier
MSCs mesenchymal stem cells (MSCs)
STEPS Stem cell Therapeutics as an Emerging Paradigm for Stroke
OGD oxygen glucose deprivation
IL-6 interleukin-6
bFGF basic fibroblast growth factor
IV intravenous
ICA intracarotid artery
ATP adenosine triphosphate
ROS reactive oxygen species
EPCs endothelial progenitor cells
HMGB1 high-mobility group box 1
RAGE receptor for advanced glycation end products
MCAO middle cerebral arterial occlusion